Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase NA 1

Status

Recruiting 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

CNS 3Gynecologic 2Breast 2Other 1

Conditions

Breast Neoplasms 2Brain Neoplasms 2Meningioma 1

Interventions

Temozolomide 400Radiotherapy 239Bevacizumab 185Magnetic Resonance Spectroscopy 168Radiosurgery 142Cyclophosphamide 95Irinotecan 79Carboplatin 79Etoposide 78Radiation 76pembrolizumab 70Nivolumab 59Surgical Procedures, Operative 57Filgrastim 56Specimen Handling 53Cisplatin 50Blood Specimen Collection 46Topotecan 45Vincristine 43Melphalan 38Radiotherapy, Intensity-Modulated 36Pemetrexed 36Lomustine 36Ipilimumab 36Everolimus 35Magnetic Resonance Imaging 34Erlotinib Hydrochloride 34Drug Therapy 34Surveys and Questionnaires 33sargramostim 30

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Neuroimaging × CNS × Clear all
NCT06377371 2026-02-27

Feasibility of Intraoperative Tracing of Meningioma Using [Cu64]DOTATATE

Weill Medical College of Cornell University

Phase 4 Recruiting
20 enrolled
CNS

Meningioma

NCT06247449 2025-12-18

MRI Screening for Brain Metastases Among Patients With Triple Negative or HER2+ Stage II or III Breast Cancer

Sunnybrook Health Sciences Centre

Phase NA Recruiting
100 enrolled
BreastCNS

Brain Neoplasms, Breast Neoplasms

NCT06072807 2025-11-24

Brain [18F]-FES PET/CT in Patients With Estrogen-Receptor Positive Breast Cancer

Weill Medical College of Cornell University

Phase 4 Recruiting
20 enrolled
BreastCNS

Brain Neoplasms, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡